- Home
- DAWN vs SSTK Comparison
DAWN vs SSTK Comparison
Compare DAWN & SSTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- SSTK
- Stock Information
- Founded
- DAWN 2018
- SSTK 2003
- Country
- DAWN United States
- SSTK United States
- Employees
- DAWN N/A
- SSTK N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- SSTK EDP Services
- Sector
- DAWN Health Care
- SSTK Technology
- Exchange
- DAWN Nasdaq
- SSTK Nasdaq
- Market Cap
- DAWN 624.8M
- SSTK 724.0M
- IPO Year
- DAWN 2021
- SSTK 2012
- Fundamental
- Price
- DAWN $7.15
- SSTK $21.59
- Analyst Decision
- DAWN Strong Buy
- SSTK Buy
- Analyst Count
- DAWN 7
- SSTK 4
- Target Price
- DAWN $27.86
- SSTK $43.67
- AVG Volume (30 Days)
- DAWN 1.1M
- SSTK 197.5K
- Earning Date
- DAWN 10-29-2025
- SSTK 10-28-2025
- Dividend Yield
- DAWN N/A
- SSTK 6.31%
- EPS Growth
- DAWN N/A
- SSTK 38.48
- EPS
- DAWN N/A
- SSTK 1.81
- Revenue
- DAWN $187,638,000.00
- SSTK $1,010,504,000.00
- Revenue This Year
- DAWN $12.56
- SSTK $11.52
- Revenue Next Year
- DAWN $48.02
- SSTK $1.15
- P/E Ratio
- DAWN N/A
- SSTK $11.54
- Revenue Growth
- DAWN 2190.50
- SSTK 14.20
- 52 Week Low
- DAWN $5.64
- SSTK $14.35
- 52 Week High
- DAWN $16.76
- SSTK $38.80
- Technical
- Relative Strength Index (RSI)
- DAWN 51.15
- SSTK 56.85
- Support Level
- DAWN $7.03
- SSTK $19.98
- Resistance Level
- DAWN $7.58
- SSTK $21.29
- Average True Range (ATR)
- DAWN 0.27
- SSTK 0.65
- MACD
- DAWN -0.04
- SSTK -0.01
- Stochastic Oscillator
- DAWN 29.55
- SSTK 87.96
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, and kinase inhibitor.
About SSTK Shutterstock Inc.
Shutterstock Inc is a U.S.-based company that is engaged in the provision of digital content. The content segment, whose offerings include licenses for Images, Footage, Music, 3 Dimensional, and Generative AI content. Data, Distribution, and Service offerings address customer demand for products and services that are beyond its Content licenses. The company generates the majority of its revenue from Content offerings. Geographically the company generates the majority of its revenue from the Domestic market, but also has its presence in Europe and Rest of the Countries.